Tenaya Therapeutics Reports Q3 Earnings Beat on Revenue and EPS
Tenaya Therapeutics (TNYA) reported third-quarter financial results that exceeded analyst expectations for both top and bottom lines. The company posted a GAAP earnings per share (EPS) of -$0.08, which outperformed estimates by $0.02. Revenue for the quarter reached $1.7 million, representing a significant beat of $0.9 million compared to consensus forecasts. These results highlight stronger-than-anticipated financial performance during the third quarter as the company continues its clinical operations.
Tickers: $TNYA
Topics: earnings beat GAAP EPS revenue beat